Adoptive immunotherapy in human and canine chimeras.
Kolb
H J
HJ
Medizinische Klinik III, Klinikum Grosshadern, Universität München.
Mittermüller
J
J
Günther
W
W
Bartram
C
C
Thalmaier
K
K
Schumm
M
M
Holler
E
E
Lederose
G
G
D000818:Animals; D000906:Antibodies / Q000276:immunology; D016026:Bone Marrow Transplantation / Q000276:immunology / Q000473:pathology; D002678:Chimera / Q000276:immunology*; D004167:Diphtheria Toxin / Q000276:immunology / Q000494:pharmacology; D004285:Dogs; D005260:Female; D006086:Graft vs Host Disease / Q000628:therapy; D006801:Humans; D016219:Immunotherapy, Adoptive; D007372:Interferons / Q000627:therapeutic use; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy; D008297:Male; D016133:Polymerase Chain Reaction; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000628:therapy; D013601:T-Lymphocytes / Q000276:immunology / Q000473:pathology
D000906:Antibodies; D004167:Diphtheria Toxin; D007372:Interferons